D. Elhardt

1.0k total citations · 1 hit paper
8 papers, 700 citations indexed

About

D. Elhardt is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, D. Elhardt has authored 8 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Otorhinolaryngology and 2 papers in Oncology. Recurrent topics in D. Elhardt's work include Oral health in cancer treatment (3 papers), Head and Neck Cancer Studies (3 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). D. Elhardt is often cited by papers focused on Oral health in cancer treatment (3 papers), Head and Neck Cancer Studies (3 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). D. Elhardt collaborates with scholars based in United States and Germany. D. Elhardt's co-authors include Thomas C. Shea, Eric Sung, Keith Hansen, Saul Yanovich, Tarun Kewalramani, Stephen J. Noga, William Bensinger, John M. McCarty, Ricardo Spielberger and Bruce R. Blazar and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of Antimicrobial Chemotherapy.

In The Last Decade

D. Elhardt

8 papers receiving 666 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

2004 606 citations Ricardo Spielberger, Patrick J. Stiff et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Elhardt United States	4	441	325	263	148	66	8	700
Christopher Fraser Australia	13	218 0.5×	261 0.8×	92 0.3×	418 2.8×	79 1.2×	33	799
Samuel Vokurka Czechia	14	358 0.8×	333 1.0×	218 0.8×	104 0.7×	65 1.0×	50	669
May Mo United States	9	508 1.2×	174 0.5×	139 0.5×	20 0.1×	43 0.7×	21	1.3k
Christine B. Boers‐Doets Netherlands	13	372 0.8×	432 1.3×	178 0.7×	13 0.1×	114 1.7×	19	806
C. Hennequin France	14	278 0.6×	241 0.7×	31 0.1×	15 0.1×	102 1.5×	72	711
M. Sanzari Italy	16	132 0.3×	264 0.8×	15 0.1×	92 0.6×	68 1.0×	25	749
Bruce R. Harrison United States	15	102 0.2×	105 0.3×	50 0.2×	76 0.5×	28 0.4×	24	619
Vicente Valentí Spain	11	197 0.4×	338 1.0×	292 1.1×	24 0.2×	68 1.0×	19	609
Cosimo Lequaglie Italy	13	285 0.6×	162 0.5×	12 0.0×	32 0.2×	32 0.5×	43	480
Julie Olsson United States	11	597 1.4×	179 0.6×	31 0.1×	7 0.0×	59 0.9×	15	1.1k

Countries citing papers authored by D. Elhardt

Since Specialization

Citations

This map shows the geographic impact of D. Elhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Elhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Elhardt more than expected).

Fields of papers citing papers by D. Elhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Elhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Elhardt. The network helps show where D. Elhardt may publish in the future.

Co-authorship network of co-authors of D. Elhardt

This figure shows the co-authorship network connecting the top 25 collaborators of D. Elhardt. A scholar is included among the top collaborators of D. Elhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Elhardt. D. Elhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Schöffski, Patrick, H.A. Burris, Jose Lutzky, et al.. (2010). 371 Phase 2 randomized discontinuation trial (RDT) of XL184 in patients (pts) with advanced solid tumors. European Journal of Cancer Supplements. 8(7). 117–117. 3 indexed citations

2.

Zia‐Amirhosseini, Parnian, Margaret Salfi, D. Elhardt, et al.. (2005). Pharmacokinetics (PK) of 2 Dosing Regimens of Palifermin in Patients (Pts) with Hematologic Malignancies (HM) Undergoing High-Dose Chemoradiotherapy and Hematopoietic Stem Cell Transplantation (HSCT).. Blood. 106(11). 5294–5294. 2 indexed citations

3.

Spielberger, Ricardo, Patrick J. Stiff, William Bensinger, et al.. (2004). Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers. New England Journal of Medicine. 351(25). 2590–2598. 606 indexed citations breakdown →

4.

Singer, Jack W., Daniel J. Weisdorf, Teresa Gentile, et al.. (2004). Palifermin reduces severe oral mucositis (OM), improves patient quality of life, and reduces health resource use in patients with hematologic malignancies receiving high-dose chemotherapy (HDCT) and total body irradiation (TBI) with autologous peripheral blood stem cell (PBSC) support: results from a phase III trial. Biology of Blood and Marrow Transplantation. 10. 31–31. 1 indexed citations

5.

Cullmann, W., et al.. (1993). Therapy of soft tissue infections with piperacillin/tazobactam. Journal of Antimicrobial Chemotherapy. 31(suppl A). 105–112. 31 indexed citations

6.

Herborn, G., et al.. (1992). [Data of two years of the comparative study methotrexate/aurothiomalate in 102 patients].. PubMed. 51(4). 163–71. 3 indexed citations

7.

Rau, R., et al.. (1991). A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: An interim report on 102 patients after 12 months. Seminars in Arthritis and Rheumatism. 21(2). 13–20. 19 indexed citations

8.

Herborn, G., et al.. (1991). A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis.. PubMed. 18(3). 328–33. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact